Susha Cheriyedath

Susha Cheriyedath

Feature Writer

B.Sc Chemistry, M.Sc. Biochemistry

Susha is a scientific communication professional holding a Master's degree in Biochemistry, with expertise in Microbiology, Physiology, Biotechnology, and Nutrition. After a two-year tenure as a lecturer from 2000 to 2002, where she mentored undergraduates studying Biochemistry, she transitioned into editorial roles within scientific publishing. She has accumulated nearly two decades of experience in medical communication, assuming diverse roles in research, writing, editing, and editorial management.

See more

Passionate about health and nutrition, Susha is interested in various diet types, such as veganism, and their impact on the body and metabolism. She remains dedicated to staying current with the latest developments in the medical and health science fields. In her leisure time, she engages in gardening, cooking/baking, and sketching/painting. When not immersed in work, she can often be found tending to her garden (weather permitting) or engrossed in her sketching and painting projects.

See less

Articles from Susha

Assessment of multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters

Assessment of multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

Impact of SARS-CoV-2 Omicron and Delta variants on serious hospital events

Impact of SARS-CoV-2 Omicron and Delta variants on serious hospital events

Assessing the association of COVID-19 and Immunoglobulin A vasculitis in children

Assessing the association of COVID-19 and Immunoglobulin A vasculitis in children

Investigating taraxerol as a protease inhibitor against SARS-CoV-2

Investigating taraxerol as a protease inhibitor against SARS-CoV-2

Fever the dominant symptom in SARS-CoV-2 Alpha- and Delta-infected children

Fever the dominant symptom in SARS-CoV-2 Alpha- and Delta-infected children

Assessing public trust and understanding of CDC’s revised COVID-19 guidelines

Assessing public trust and understanding of CDC’s revised COVID-19 guidelines

Booster dose of Pfizer-BioNTech COVID vaccine protects elderly against Omicron

Booster dose of Pfizer-BioNTech COVID vaccine protects elderly against Omicron

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.